Critical Comparison: Express Scripts (ESRX) vs. 111 (YI)

Express Scripts (NASDAQ:ESRX) and 111 (NASDAQ:YI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Analyst Ratings

This is a breakdown of current ratings for Express Scripts and 111, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Express Scripts 1 13 3 0 2.12
111 0 0 1 0 3.00

Express Scripts currently has a consensus price target of $90.54, suggesting a potential downside of 5.54%. Given Express Scripts’ higher probable upside, equities research analysts clearly believe Express Scripts is more favorable than 111.

Profitability

This table compares Express Scripts and 111’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Express Scripts 4.83% 25.43% 8.94%
111 N/A N/A N/A

Insider & Institutional Ownership

85.0% of Express Scripts shares are held by institutional investors. Comparatively, 4.3% of 111 shares are held by institutional investors. 0.8% of Express Scripts shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Express Scripts and 111’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Express Scripts $100.06 billion 0.54 $4.52 billion $7.10 13.50
111 $145.00 million 4.19 -$37.56 million N/A N/A

Express Scripts has higher revenue and earnings than 111.

Summary

Express Scripts beats 111 on 9 of the 11 factors compared between the two stocks.

Express Scripts Company Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

111 Company Profile

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. It also offers a suite of cloud-based solutions and Internet-based software services, including the provision of access to business applications and service modules, such as customer relationship management, supply chain management, online medical consultation, e-prescriptions, digital contract sales organization, and precision marketing. In addition, the company is involved in warehousing, logistics, procurement, research and development, and consulting activities; and software development and information technology support businesses. As of June 30, 2018, 111, Inc. had a network of 12 offline retail pharmacies branded as Yi Hao Pharmacy in Guangzhou, Shanghai, Tianjin, and Kunshan. It services pharmacies, pharmaceutical companies, medical professionals and consumers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2012 and is headquartered in Shanghai, China.

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply